Suzuki, H.; Ozawa, K.; Tanaka, T.; Kaneko, M.K.; Kato, Y.
Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C44Mab-34, for Multiple Applications against Oral Carcinomas. Biomedicines 2023, 11, 1099.
https://doi.org/10.3390/biomedicines11041099
AMA Style
Suzuki H, Ozawa K, Tanaka T, Kaneko MK, Kato Y.
Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C44Mab-34, for Multiple Applications against Oral Carcinomas. Biomedicines. 2023; 11(4):1099.
https://doi.org/10.3390/biomedicines11041099
Chicago/Turabian Style
Suzuki, Hiroyuki, Kazuki Ozawa, Tomohiro Tanaka, Mika K. Kaneko, and Yukinari Kato.
2023. "Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C44Mab-34, for Multiple Applications against Oral Carcinomas" Biomedicines 11, no. 4: 1099.
https://doi.org/10.3390/biomedicines11041099
APA Style
Suzuki, H., Ozawa, K., Tanaka, T., Kaneko, M. K., & Kato, Y.
(2023). Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C44Mab-34, for Multiple Applications against Oral Carcinomas. Biomedicines, 11(4), 1099.
https://doi.org/10.3390/biomedicines11041099